This bill requires the Substance Abuse and Mental Health Services Administration (SAMHSA) to award grants to eligible jurisdictions and community-based organizations to address the harms of substance misuse, including by encouraging actions to reduce health impacts of substance use during national disasters and emergencies. SAMHSA shall prioritize grants by accounting for such factors as drug overdose death rates.
Get AI-generated questions to help you understand this bill better
Timeline
Introduced in House
Referred to the House Committee on Energy and Commerce.
Introduced in House
Referred to the House Committee on Energy and Commerce.
Health
Cardiovascular and respiratory healthDigestive and metabolic diseasesDrug, alcohol, tobacco useEmergency medical services and trauma careHealth programs administration and fundingHealth promotion and preventive careHealth technology, devices, suppliesHIV/AIDSInfectious and parasitic diseasesMental health
To authorize grants to address substance use during COVID-19.
USA116th CongressHR-6620| House
| Updated: 4/24/2020
This bill requires the Substance Abuse and Mental Health Services Administration (SAMHSA) to award grants to eligible jurisdictions and community-based organizations to address the harms of substance misuse, including by encouraging actions to reduce health impacts of substance use during national disasters and emergencies. SAMHSA shall prioritize grants by accounting for such factors as drug overdose death rates.
Cardiovascular and respiratory healthDigestive and metabolic diseasesDrug, alcohol, tobacco useEmergency medical services and trauma careHealth programs administration and fundingHealth promotion and preventive careHealth technology, devices, suppliesHIV/AIDSInfectious and parasitic diseasesMental health